Evaluation of in vitro antibacterial activity of enoxacin: Comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits

This publication has 12 references indexed in Scilit:

• Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations
  Antimicrobial Agents and Chemotherapy, 1984
• In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim
  Antimicrobial Agents and Chemotherapy, 1983
• In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits
  Antimicrobial Agents and Chemotherapy, 1983
• In vitro and in vivo antibacterial activity of AT-2266
  Antimicrobial Agents and Chemotherapy, 1983
• Pharmacokinetics of AT-2266 Administered Orally to Mice, Rats, Dogs, and Monkeys
  Antimicrobial Agents and Chemotherapy, 1983
• Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice
  Antimicrobial Agents and Chemotherapy, 1983
• In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound
  Antimicrobial Agents and Chemotherapy, 1983
• In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid
  Antimicrobial Agents and Chemotherapy, 1983
• In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains
  Antimicrobial Agents and Chemotherapy, 1980
• Susceptibility Tests of Anaerobic Bacteria: Statistical and Clinical Considerations
  The Journal of Infectious Diseases, 1974